1

The comparative efficacy and safety of basiliximab and antithymocyte globulin in deceased donor kidney transplantation: a multicenter cohort study

livozj48sry0
Background Generally. an induction agent is chosen based on the conditions of the deceased donor and the recipient. Antithymocyte globulin (ATG) is preferred in relatively high-risk conditions. No clear evidence indicates which induction agent is safer or more efficient for deceased donor kidney transplantation (DDKT). https://fitnessgravesyardes.shop/product-category/audio-receiver/
Report this page

Comments

    HTML is allowed

Who Upvoted this Story